Many enterprise partnerships on this planet of diabetes care have been introduced in current months — a lot of which contain sharing and integrating drug and gadget applied sciences. But the most recent collaboration might have one of many largest impacts on older adults with diabetes, although it’s a reasonably simple retail announcement.
Dexcom, maker of the G6 steady glucose monitoring (CGM) system, and Walgreens have introduced that the gadget will now be out there below Medicare at all the pharmacy chain’s greater than 9,200 places within the United States. This signifies that for anybody on Medicare whose physician prescribes the G6, getting began on the system is as straightforward as dropping by your native pharmacy.
To get cutting-edge diabetes information, methods for blood glucose administration, diet ideas, wholesome recipes, and extra delivered straight to your inbox, join for our free e-newsletter!
As defined in a Walgreens press launch, prescriptions for CGM techniques below Medicare Part B should be stuffed by sturdy medical gear suppliers, producers and restricted pharmacies — which largely excludes retail pharmacies. Walgreens and Dexcom have collaborated to invoice Medicare as a sturdy medical gear provider whereas providing the comfort of retail places, a mix that hasn’t been out there till now.
Walgreens additionally introduced within the press launch that it is going to be working with different CGM producers to provide their merchandise at retail places below the identical Medicare billing mannequin. Like many different pharmacies, the chain already accepts industrial insurance coverage for a number of CGM units.
CGM techniques are usually prescribed to individuals with diabetes who take a number of day by day insulin injections or put on an insulin pump, and wish to ceaselessly monitor their blood glucose ranges to make therapy choices. This can embrace individuals with each sort 1 and sort 2 diabetes.
“Research continues to demonstrate CGM should be the standard of care for all diabetes patients on intensive insulin therapy,” says Kevin Sayer, govt chairman president and CEO of Dexcom, within the press launch. “Getting the Dexcom G6 into the hands of Medicare patients through Walgreens pharmacies is a significant step forward in increasing access to the most powerful diabetes management tool available.”
Want to be taught extra about CGM? Read “CGM for Diabetes Management” and “How to Pick an Insulin Pump or CGM.”
A contract well being author and editor based mostly in Wisconsin, Phillips has a level in authorities from Harvard University. He writes on quite a lot of matters, however is very within the intersection of well being and public coverage.
(Image: Sundry Photography / Shutterstock.com)